Browse Category by Doctors
Doctors, Urologist

Dr. David Samadi: Mitt Romney’s Prostate Cancer Prognosis Good

For Mitt Romney, his decision to treat his prostate cancer with surgery instead of radiation may have saved his life, according to Dr. David Samadi. Other politicians like presidential nominee John Kerry and Colin Powell, the former Secretary of State, have also had surgery to remove the prostate after a diagnosis of cancer. In 2017, former Presidential nominee for the Republican party, Mitt Romney, became part of the statistic of 161,360 prostate cancer diagnoses that year. It’s expected to reach 164,690 new diagnoses in 2018 according to the American Cancer Society.

On average, 60% of the men diagnosed with prostate cancer are over the age of 65 with an average age of 66. It is rare that men under 40 are diagnosed. Mitt Romney was 70 at the time of his diagnosis.

Dr. David Samadi discusses the options for treatments after a prostate cancer diagnosis. In almost every case where they are able to localize the cancer to the prostate, he recommends surgery. There is almost a 100% survival rate for patients who choose surgery after localization. Patients who choose radiation over surgery are more likely to develop secondary cancer from the damaging effects on a genetic level after treatment. They are also twice as likely to die and 1.5 times less likely to live longer than a patient who chose surgery.

Dr. David Samadi immigrated from Iran in 1979 after their revolution with his younger brother. He and his brother moved to Belgium at the ages of 15 and 19 without their parents. The two continued their education throughout Belgium, London, and the United States.

Dr. David Samadi is currently a Fox News Consultant and Contributor as well as the Chief of Robotic Surgery at Lenox Hill Hospital as well as the Chairman of Urology since June of 2013. He brought his entire surgical team with him from his previous position at Mt. Sinai Medical School where he was the Vice Chair of Urology and the Chief of Robotic Surgery. From 2002 to 2007, he served as the Director of Laparoscopic Surgery at Columbia Presbyterian Medical Center in New York after completing his education.

Samadi resides in Old Westbury, New York and is married to Iranian born Sahar Danielpour. The couple has two children, a boy and a girl who are happy and healthy. The Samadi’s believes highly in love, loyalty, and devotion to family and the United States.



Eric Lefkofsky’s Digital War on Cancer

Lefkofsky’s Interest In Genomic Medicine

The serial entrepreneur Eric Lefkofsky is interested in cancer research. It is now possible to sequence a whole genome of a patient. There has also been a recent FDA approval to target very specific cancers based on a specific genomic profile. Tempus Therapeutics has assembled a team of researchers aimed at solving the cancer problem to determine why some patients are able to respond to new and novel immunotherapies for cancer, while other patients simply can’t.

Computers Used Increasingly Across A Wide Range of Fields

Computer vision is used to analyze biopsy images, and natural language processing is used for clinical records. When all is said and done, cancer is now a computational game as scientists use the best computational tools to find the appropriate cures. Every achievement has resulted in a disruptive new technology aimed at improving humanity, along with understanding the innate human survival characteristics that are programmed into the genome.

Physicians Empowered To Make Decisions Based on Data

Tempus is a company that is empowering physicians to make decisions based on data. They are also in the business of providing genomic and transcriptomic sequencing services. This enables physicians to better understand the inner workings of the human body, and find new cures for diseases. Data is a much more accurate and precise way of making health decisions rather than strictly using human judgement and intuition.

Eric Lefkofsky’s Successful Track Record

Tempus isn’t Eric Lefkofsky’s first success. He’s also the co-founder of Groupon. His first entrepreneurial success is InnerWorkings, which is a company that specializes in providing promotional products to customers. This was followed by a logistics company, and the acquisition of a media company. Groupon was a venture which was created by Andrew Mason, for which Lefkofsky provided $1 million in seed funding.